Skip to main content
    H

    Health In Tech, Inc. Class A Common Stock (HIT)

    Official site

    TECHNOLOGY • SOFTWARE - APPLICATION • NASDAQ

    $0.33
    -0.07 (-16.61%)

    Market Cap: $25.83M

    Last updated: Nov 17, 2026 at 11:00 AM ET

    Health In Tech, Inc. Class A Common Stock (HIT) Financials: Revenue, Profit and Cash Flow

    Updated Nov 12, 2026. Financial statements from company filings, amounts in US dollars.

    Health In Tech, Inc. Class A Common Stock reported revenue of $33.33M for the fiscal year ended Dec 31, 2025, up 71.0% from the year before. That year, net income was $1.28M with a net margin of 3.8%, operating cash flow was $3.13M and free cash flow was -$56.11K. The quarter ended Sep 30, 2026 had revenue of $6.59M and net income of -$7.11M.

    Revenue and Margins

    The operating margin was 4.6% in the fiscal year ended Dec 2025.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$33.33M+71.0%62.8%4.6%3.8%
    Dec 2024$19.49M+1.8%79.2%5.1%3.4%
    Dec 2023$19.15M+231.9%88.0%17.7%20.7%
    Dec 2022$5.77MN/A94.2%3.6%1.4%
    Annual, fiscal years ended Dec 2022 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 90.9% from the year before. In the quarter ended Sep 2026, the company posted a net loss after a profit in the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022
    Revenue$33.33M$19.49M$19.15M$5.77M
    Cost of revenue$12.39M$4.05M$2.30M$334.19K
    Gross profit$20.94M$15.44M$16.85M$5.44M
    Research and development$1.57M$2.81M$2.00M$794.62K
    Operating income$1.53M$989.90K$3.38M$205.58K
    Net income$1.28M$670.48K$3.96M$79.74K
    EBITDA$2.16M$2.30M$3.72M$205.58K
    Fiscal years ended Dec 2022 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$6.59M$8.06M$8.77M$7.51M$8.49M$9.31M$8.01M$4.90M$4.46M$5.00M$5.12M$5.22M
    Gross profit$3.06M$3.92M$4.51M$4.13M$5.14M$6.31M$5.36M$3.80M$3.48M$4.03M$4.14M$4.26M
    Operating income-$8.39M-$3.44M-$2.16M-$170.81K$493.52K$725.07K$480.66K-$316.34K$438.88K$534.94K$332.42K$1.46M
    Net income-$7.11M-$2.51M-$1.59M-$302.56K$452.18K$630.63K$498.59K-$144.15K$376.09K$338.01K$100.54K$1.00M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $0 by $7.67M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022
    Total assets$23.09M$15.77M$11.50M$28.56M
    Current assets$16.16M$10.78M$6.86M$25.43M
    Cash and equivalents$7.67M$7.85M$2.42M$1.49M
    Total liabilities$5.98M$2.60M$5.41M$27.14M
    Short-term debt$0$66.88K$1.65M$50.72K
    Shareholder equity$17.11M$13.17M$6.09M$1.05M
    Fiscal years ended Dec 2022 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$28.03M$29.63M$28.97M$23.09M$22.76M$22.18M$21.33M$15.77M$9.67M$10.76M$10.44M$11.50M
    Total liabilities$15.15M$10.01M$7.36M$5.98M$5.60M$5.75M$7.17M$2.60M$2.76M$4.23M$4.25M$5.41M
    Cash and equivalents$10.13M$6.51M$10.33M$7.67M$8.02M$8.14M$7.58M$7.85M$1.75M$2.16M$1.36M$2.42M
    Shareholder equity$12.85M$19.55M$21.60M$17.11M$17.16M$16.42M$14.16M$13.17M$6.91M$6.53M$6.19M$6.09M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, capital expenditures exceeded operating cash flow, leaving negative free cash flow.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022
    Operating cash flow$3.13M$2.18M$1.53M$782.75K
    Capital expenditures$3.19M$900.75K$1.14M$1.22M
    Free cash flow-$56.11K$1.28M$384.52K-$436.63K
    Dividends paidN/AN/A$44.35KN/A
    Investing cash flow-$3.13M-$836.75K-$1.94M-$1.22M
    Financing cash flow-$187.39K$4.09M$1.34M$1.88M
    Fiscal years ended Dec 2022 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$1.05M-$2.91M-$3.32M$451.21K$673.97K$1.48M$527.35K-$531.17K$2.12M$1.27M-$680.21K-$405.58K
    Capital expenditures$842.16K$596.99K$362.13K$831.71K$744.84K$909.90K$703.48K$606.12K$67.28K$93.96K$133.39K$277.65K
    Free cash flow-$1.89M-$3.51M-$3.68M-$380.50K-$70.87K$571.38K-$176.12K-$1.14M$2.05M$1.17M-$813.61K-$683.23K
    Last 12 quarters

    Frequently Asked Questions About HIT

    What is Health In Tech, Inc. Class A Common Stock's annual revenue?

    Health In Tech, Inc. Class A Common Stock reported revenue of $33.33M for the fiscal year ended Dec 31, 2025.

    How fast is Health In Tech, Inc. Class A Common Stock's revenue growing?

    Revenue was up 71.0% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 79.4%.

    Is Health In Tech, Inc. Class A Common Stock profitable?

    Yes. Health In Tech, Inc. Class A Common Stock reported net income of $1.28M for the fiscal year ended Dec 31, 2025, with a net margin of 3.8%.

    How much free cash flow does HIT generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $3.13M minus capital expenditures of $3.19M produced free cash flow of -$56.11K.

    How much debt does Health In Tech, Inc. Class A Common Stock have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $0 and cash and equivalents of $7.67M.